Pre-screening of the gut microbiome may lead to a more personalized approach to treating intestinal parasitic worm infections, leading to better treatment outcomes and a decreased risk for drug resistance.
Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.